Charitable Trust Mihara Cerebrovascular Disorder Research Promotion Fund Mihara Award
Japanese
go to main navigation
Home Greeting from the Chairman Prospectus Outline Selection
Application Procedure Praise Award Recipients Past Winners Award Ceremony

Outline

Fund Name: Charitable Trust Mihara Cerebrovascular Disorder Research Promotion Fund
Objective: In recognition of the urgent need in Japan for further basic and clinical studies on cerebrovascular disorders, to provide individual research grants to assist investigators undertaking such studies, thereby promoting the aims of medical science in this respect and human welfare in general.
Project To Be Funded: Studies by researchers engaged in work on the basic or clinical aspects of cerebrovascular disorders.
Amount Of Grant-In-Aid: 10 million yen (per award)
Consignor: The late Hiroshi Mihara, M.D.
Trustee: MizuhoTrust & Banking Co.,Ltd.
Administrator of the Trust: Motohisa Furukawa (Member of the House of Representatives)
Members Of Steering Committee:
Chairman Akira Tamura
(Fuji Brain Institute & Hospital)
  Nobuo Araki
(Vice Dean of School of Medicine Professor Emeritus and Chairman Department of Neurology Saitama Medical University)
  Yoshio Ikeda
(Professor, Department of Neurology, Gunma University Graduate School of Medicine)
  Tomonori Hasegawa
(Professor & Chairperson, Division of Health Policy & Health Service Research Department of Social Medicine Toho University School of Medicine)
  Sadao Suga
(Professor, Department of Neurosurgery Tokyo Dental College Ichikawa General Hospital)
  Masaki Takao
(Director, Department of Clinical Laboratory and Internal Medicine National Center of Neurology and Psychiatry)
  Ban Mihara
(Director, Institute of Brain and Blood Vessels Mihara Memorial Hospital)
Initial Trust Fund : 300 Million Yen
Ministry In Charge:

Ministry of Education, Culture, Sports, Science and Technology

back to main navigation
return to the head of this page
Copyright © 2004 Charitable Trust Mihara Cerebrovascular Disorder Research Promotion Fund. All rights reserved.